Company Overview of Tinea Pharmaceuticals, Inc.
Tinea Pharmaceuticals, Inc., a biopharmaceutical company, develops products for the treatment of onychomycosis or fungal infections of the toenail and nail bed. Its Luliconazole is a topical antifungal agent against a range of pathogens, including Trichophyton rubrum, Trichophyton mentagrophytes, and yeasts. The company was formerly known as Topica Pharmaceuticals, Inc. and changed its name to Tinea Pharmaceuticals, Inc. in September 2010. The company was founded in 2004 and is based in Palo Alto, California.
435 Tasso Street
Palo Alto, CA 94301-1555
Founded in 2004
Key Executives for Tinea Pharmaceuticals, Inc.
Tinea Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Tinea Pharmaceuticals, Inc., please visit www.topicapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.